The origin and evolutionary history of HIV-1 subtype C in Senegal

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Jung, Matthieu ^a,b   Leye, Nafissatou ^a,c   Vidal, Nicole ^a   Fargette, Denis ^d   Diop, Halimatou ^c   Kane, Coumba ^c   Gascuel, Olivier ^b   Peeters, Martine ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b LIRMM   (France)

^c Laboratory of Bacteriology and Virology   (Senegal)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; POL PROTEIN;

AFRICA; ARTICLE; BAYES THEOREM; CONTROLLED STUDY; GENE CLUSTER; GENETIC VARIABILITY; GEOGRAPHIC ORIGIN; HIGH RISK BEHAVIOR; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE HOMOSEXUAL; MOLECULAR EVOLUTION; MOST RECENT COMMON ANCESTOR; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGANISMS BY PHYLOGENETIC POSITION; PHYLOGENY; SENEGAL; SEXUAL BEHAVIOR; STRUCTURAL GENE; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; SEQUENCE ANALYSIS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

BAYES THEOREM; EVOLUTION, MOLECULAR; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; SENEGAL; SEQUENCE ANALYSIS, RNA;

EID: 84859029646     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033579     Document Type: Article

References (55)

1. Thomson MM, Pérez-Alvarez L, Nájera R, (2002) Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2: 461-71 Review.
2. Peeters M, Aghokeng AF, Delaporte E, (2010) Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays. Clin Microbiol Infect 16: 1525-31 Review.
3. Gamble LJ, Matthews QL, (2010) Current progress in the development of a prophylactic vaccine for HIV-1. Drug Des Devel Ther 5: 9-26 Review.
4. Tebit DM, Arts EJ, (2011) Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis 11: 45-56 Review.
5. Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, et al. (2000) Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 74: 10498-507.
6. Rambaut A, Robertson DL, Pybus OG, Peeters M, Holmes EC, (2001) Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature 410: 1047-8.
7. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, et al. (2008) Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455: 661-4.
8. Hemelaar J, Gouws E, Ghys PD, Osmanov S, WHO-UNAIDS Network for HIV Isolation and Characterisation (2011) Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25: 679-89.
9. Barin F, M'Boup S, Denis F, Kanki P, Allan JS, et al. (1985) Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet 2: 1387-9.
10. Hamel DJ, Sankalé JL, Eisen G, Meloni ST, Mullins C, et al. (2007) Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. AIDS Res Hum Retroviruses 23: 1189-96.
11. UNAIDS website. Available: www.unaids.org/en/regionscountries/countries/senegal/. Accessed 2011 Aug 23.
12. Toure-Kane C, Montavon C, Faye MA, Gueye PM, Sow PS, et al. (2000) Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence. AIDS Res Hum Retroviruses 16: 603-9.
13. Ayouba A, Lien TT, Nouhin J, Vergne L, Aghokeng AF, et al. (2009) Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study. AIDS Res Hum Retroviruses 25: 1193-6.
14. Diop-Ndiaye H, Toure-Kane C, Leye N, Ngom-Gueye NF, Montavon C, et al. (2010) Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal. AIDS Res Hum Retroviruses 26: 1133-8.
15. Ndiaye HD, Toure-Kane C, Vidal N, Niama FR, Niang-Diallo PA, et al. (2009) Surprisingly high prevalence of subtype C and specific HIV-1 subtype/CRF distribution in men having sex with men in Senegal. J Acquir Immune Defic Syndr 52: 249-52.
16. Soares EA, Martinez AM, Souza TM, Santos AF, Da Hora V, et al. (2005) HIV-1 subtype C dissemination in southern Brazil. AIDS 19 (Suppl 4S81)-86.
17. Wade AS, Kane CT, Diallo PAN, Diop AK, Gueye K, et al. (2005) HIV infection and sexually transmitted infections among men who have sex with men in Senegal. AIDS 19: 2133-2140.
18. Thomson MM, Fernández-García A, (2011) Phylogenetic structure in African HIV-1 subtype C revealed by selective sequential pruning. Virology 415: 30-8.
19. Fontella R, Soares MA, Schrago CG, (2008) On the origin of HIV-1 subtype C in South America. AIDS 22: 2001-11.
20. Bello G, Passaes CP, Guimarães ML, Lorete RS, Matos Almeida SE, et al. (2008) Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS 22: 1993-2000.
21. de Oliveira T, Pillay D, Gifford RJ, UK Collaborative Group on HIV Drug Resistance (2010) The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS One 5 (2): e9311.
22. Véras NM, Gray RR, Brígido LF, Rodrigues R, Salemi M, (2011) High-resolution phylogenetics and phylogeography of human immunodeficiency virus type 1 subtype C epidemic in South America. J Gen Virol 92: 1698-709.
23. Kane F, Alary M, Ndoye I, Coll AM, M'boup S, et al. (1993) Temporary expatriation is related to HIV-1 infection in rural Senegal. AIDS 9: 1261-5.
24. Kanki PJ, Peeters M, Gueye-Ndiaye A, (1997) Virology of HIV-1 and HIV-2: implications for Africa. AIDS 11 (Suppl B): S33-4.
25. Kanki PJ, Hamel DJ, Sankalé JL, Hsieh C, Thior I, et al. (1999) Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179: 68-73.
26. Tully DC, Wood C, (2010) Chronology and evolution of the HIV-1 subtype C epidemic in Ethiopia. AIDS 24: 1577-82.
27. Dalai SC, de Oliveira T, Harkins GW, Kassaye SG, Lint J, et al. (2009) Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. AIDS 23: 2523-32.
28. Travers SA, Clewley JP, Glynn JR, Fine PE, Crampin AC, et al. (2004) Timing and reconstruction of the most recent common ancestor of the subtype C clade of human immunodeficiency virus type 1. J Virol 78: 10501-6.
29. McDaid LM, Hart GJ, (2010) Sexual risk behaviour for transmission of HIV in men who have sex with men: recent findings and potential interventions. Curr Opin HIV AIDS 5: 311-5 Review.
30. Abraha A, Nankya IL, Gibson R, Demers K, Tebit DM, et al. (2009) CCR5-and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic, J Virol 83: 5592-5605.
31. Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, et al. (2003) Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 77: 1021-38.
32. Renjifo B, Gilbert P, Chaplin B, Msamanga G, Mwakagile D, et al. (2004) Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 18: 1629-1636.
33. John-Stewart GC, Nduati RW, Rousseau CM, Mbori-Ngacha DA, Richardson BA, et al. (2005) Subtype C is associated with increased vaginal shedding of HIV-1. J Infect Dis 192: 492-496.
34. Martinez-Cajas JL, Pai NP, Klein MB, Wainberg MA, (2009) Differences in resistance mutations among HIV-1 non-subtype B infections: A systematic review of evidence (1996-2008). J Int AIDS Soc 12: 11.
35. Vergne L, Snoeck J, Aghokeng A, Maes B, Valea D, et al. (2006) Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients. FEMS Immunol Med Microbiol 46: 53-62.
36. Snoeck J, Kantor R, Shafer RW, Van Laethem K, Deforche K, et al. (2006) Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent. Antimicrob Agents Chemother 50: 694-701.
37. Neilson JR, John GC, Carr JK, Lewis P, Kreiss JK, et al. (1999) Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 73: 4393-4403.
38. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF, (2008) The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther 13 (Suppl 2): 1-13.
39. de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, et al. (2005) An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 21: 3797-800.
40. Alcantara LC, Cassol S, Libin P, Deforche K, Pybus OG, et al. (2009) Standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res 37: 634-42.
41. Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, et al. (2006) HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon. Antivir Ther 11: 575-9.
42. Katoh K, Misawa K, Kuma K, Miyata T, (2002) MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30: 3059-3066.
43. Katoh K, Kuma K, Toh H, Miyata T, (2005) MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res 33: 511-8.
44. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol 28: 2731-9.
45. Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, et al. (2009) Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One pp. e4724.
46. Posada D, Crandall KA, (2001) Selecting models of nucleotide substitution: an application to human immunodeficiency virus 1 (HIV-1). Mol Biol Evol 18: 897-906.
47. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, et al. (2010) New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59: 307-21.
48. Anisimova M, Gascuel O, (2006) Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative. Syst Biol 55: 539-52.
49. Ronquist F, Huelsenbeck JP, (2003) MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19: 1572-1574.
50. Drummond AJ, Rambaut A, (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
51. Drummond AJ, Ho SYW, Phillips MJ, Rambaut A, (2006) Relaxed phylogenetics and dating with confidence. PLoS Biol 4: e88.
52. Minin VN, Bloomquist EW, Suchard MA, (2008) Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. Mol Biol Evol 25: 1459-71.
53. Brown BK, Darden JM, Tovanabutra S, Oblander T, Frost J, et al. (2005) Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. J Virol 79: 6089-101.
54. Vergne L, Kane CT, Laurent C, Diakhaté N, Gueye NF, et al. (2003) Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy. AIDS 17 (Suppl 3): S31-8.
55. Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, et al. (2000) Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naïve patients. J Clin Microbiol 38: 3919-25.